7-氯-2,8-二甲基喹啉
|
C336781-1g
|
|
120370-62-9 |
1g
|
¥ 2651.9
|
期货,请咨询 |
阿拉丁 |
7-氯-2,8-二甲基喹啉
|
C336781-500mg
|
|
120370-62-9 |
500mg
|
¥ 1604.9
|
期货,请咨询 |
阿拉丁 |
COX-2抑制剂I
|
C336773-5mg
|
|
416901-58-1 |
5mg
|
¥ 1793.9
|
期货,请咨询 |
阿拉丁 |
Cdk4/6 Inhibitor IV
|
C336771-5mg
|
≥95% |
359886-84-3 |
5mg
|
¥ 1779.9
|
期货,请咨询 |
阿拉丁 |
2-氯-4,6-双[3-(全氟己基)丙氧基]-1,3,5-三嗪
|
C336744-10g
|
≥95% |
916770-15-5 |
10g
|
¥ 7414.9
|
现货 |
阿拉丁 |
2-氯-4,6-双[3-(全氟己基)丙氧基]-1,3,5-三嗪
|
C336744-1g
|
≥95% |
916770-15-5 |
1g
|
¥ 1430.9
|
现货 |
阿拉丁 |
9-氯-2-甲氧基-吖啶
|
C336738-250mg
|
|
16492-13-0 |
250mg
|
¥ 880.9
|
期货,请咨询 |
阿拉丁 |
21-氯-16β-甲基-17-(1-氧代丙氧基)孕甾-1,4-二烯-3,20-二酮
|
C336701-10mg
|
|
95796-50-2 |
10mg
|
¥ 94123.9
|
期货,请咨询 |
阿拉丁 |
2'-C-甲基5'-胞苷酸
|
C336675-10mg
|
|
386213-38-3 |
10mg
|
¥ 2441.9
|
期货,请咨询 |
阿拉丁 |
Cdk1抑制剂
|
C336671-5mg
|
Moligand™, ≥95% |
220749-41-7 |
5mg
|
¥ 592.9
|
现货 |
阿拉丁 |
Cdk / Crk抑制剂
|
C336669-1mg
|
Moligand™, ≥95% |
784211-09-2 |
1mg
|
¥ 2022.9
|
期货,请咨询 |
阿拉丁 |
Cdk4抑制剂
|
C336666-1mg
|
Moligand™ |
546102-60-7 |
1mg
|
¥ 1084.9
|
期货,请咨询 |
阿拉丁 |
Cdk2 / 9抑制剂
|
C336661-5mg
|
|
507487-89-0 |
5mg
|
¥ 2775.9
|
期货,请咨询 |
阿拉丁 |
氯氮平-d8
|
C336634-1mg
|
≥98 atom% D,≥98% |
1185053-50-2 |
1mg
|
¥ 1743.9
|
现货 |
阿拉丁 |
化合物56
|
C336633-500μg
|
Moligand™, ≥97% |
171745-13-4 |
500μg
|
¥ 1144.9
|
期货,请咨询 |
阿拉丁 |
CGP-74514A盐酸盐
|
C336625-25mg
|
|
1173021-98-1 |
25mg
|
¥ 5551.9
|
期货,请咨询 |
阿拉丁 |
CGP-74514A盐酸盐
|
C336625-5mg
|
|
1173021-98-1 |
5mg
|
¥ 1535.9
|
期货,请咨询 |
阿拉丁 |
盐酸CDKi
|
C336624-5mg
|
≥98% |
70035-83-5 |
5mg
|
¥ 2577.9
|
现货 |
阿拉丁 |
Cdk1 / 2抑制剂III
|
C336620-1mg
|
Moligand™, ≥95% |
443798-55-8 |
1mg
|
¥ 1382.9
|
期货,请咨询 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-5mg
|
≥97% |
396073-89-5 |
5mg
|
¥ 932.9
|
期货,请咨询 |
阿拉丁 |
2-(氯甲基)烯丙基三甲基硅烷
|
C336612-1g
|
≥97% |
18388-03-9 |
1g
|
¥ 1419.9
|
期货,请咨询 |
阿拉丁 |
4-(氯甲基)苯基三氯硅烷
|
C336608-5g
|
≥96% |
13688-90-9 |
5g
|
¥ 357.9
|
期货,请咨询 |
阿拉丁 |
2-氯-4-硝基苯基-α-D-麦芽三糖苷
|
C336594-1g
|
≥95% |
118291-90-0 |
1g
|
¥ 3706.9
|
现货 |
阿拉丁 |
5-氯-2,4-二甲氧基嘧啶
|
C336573-5g
|
≥97% |
123551-49-5 |
5g
|
¥ 1057.9
|
现货 |
阿拉丁 |